Privia Health Group Inc (PRVA)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $3.14B
Last updated: Nov 17, 2026 at 11:06 AM ET
Privia Health Group Inc (PRVA) Stock Forecast
Analysts expect Privia Health Group (PRVA) to earn $0.85 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.53B. Of 18 analysts, 17 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.03.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 18 ratings average 1.78, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 94% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 5 | 27.8% |
| Buy | 12 | 66.7% |
| Hold | 1 | 5.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 18
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 21.2% and revenue estimates rise 9.5%.
- Fiscal year ending Dec 31, 2026
- $0.85
- EPS consensus, revenue $2.53B
- Fiscal year ending Dec 31, 2027
- $1.03
- EPS consensus, revenue $2.77B
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.85 | $0.77 to $1.24 | 10 | $2.53B | $2.45B to $2.56B | 14 |
| Dec 31, 2027 | $1.03 | $0.88 to $1.40 | 10 | $2.77B | $2.64B to $2.92B | 14 |
Quarterly Estimates
The EPS consensus rises from $0.12 for the quarter ending Dec 31, 2026 to $0.26 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.12 | $0.09 to $0.16 | 20 | $653.55M | $613.97M to $689.75M | 19 |
| Mar 31, 2027 | $0.26 | $0.20 to $0.33 | 5 | $665.12M | $625.00M to $707.70M | 8 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 6 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 5 | 5 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 8.6% from $0.93.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.85 | $0.89 | $0.89 | $0.88 | $0.93 | -8.2% |
| Fiscal year ending Dec 31, 2027 | $1.03 | $1.06 | $1.06 | $1.06 | $1.08 | -4.9% |
| Quarter ending Mar 31, 2027 | $0.26 | $0.31 | $0.31 | $0.31 | $0.30 | -15.4% |
Frequently Asked Questions About PRVA
What is the PRVA stock forecast?
Consensus analyst estimates put Privia Health Group's EPS at $0.85 for the fiscal year ending Dec 31, 2026, on revenue of $2.53B. The consensus rating from 18 analysts is Buy.
How do analysts rate PRVA stock?
Of 18 analysts covering Privia Health Group, 5 rate it Strong Buy, 12 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PRVA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.85, with estimates from $0.77 to $1.24 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.03, with estimates from $0.88 to $1.40 from 10 analysts.
What revenue do analysts expect from Privia Health Group next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.53B, with estimates from $2.45B to $2.56B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.77B, with estimates from $2.64B to $2.92B.
How many analysts cover PRVA?
18 analysts rate Privia Health Group stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PRVA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors